Read this company snapshot
Daily valuation snapshot
Instil Bio, Inc. Common Stock: source evidence dated 2026-10-09.
- Daily close (USD)
- $6.74
- Market capitalization (USD)
- $45,710,518.24
- Price / earnings (TTM)
- Not reported
- Price / book
- 0.43
The source values and product destination above identify the example to inspect.
What business is this, and what does its dated valuation mean?
Check the market day first. P/E uses trailing earnings; book value and market capitalization answer different questions.
Daily valuation dataset and column definitionsOpen the company research view or ask Aurora to reconcile reporting periods, earnings, debt and the figures behind the valuation.
Research TIL in the app
Open the company research view or ask Aurora to reconcile reporting periods, earnings, debt and the figures behind the valuation.
Research TIL in the appKeep reporting dates and units beside the answer, and inspect its original citations.
Company overview
Instil Bio, Inc., a clinical-stage biopharmaceutical company, focuses on developing a pipeline of novel therapies. Its lead products candidate is AXN-2510/IMM2510 that is in Phase 1b/2 clinical trial for the treatment of patients with chemotherapy in patients with advanced/metastatic non-small cell lung cancer. The company also conducts a Phase 1 open label trial in China for AXN-2510/IMM2510 as monotherapy in patients with advanced solid tumors, including triple-negative breast cancer, squamous non-small cell lung cancer, hepatocellular carcinoma, renal cell carcinoma, and rare solid tumors, such as soft tissue sarcomas and thymic cancer. Instil Bio, Inc. was incorporated in 2018 and is headquartered in Dallas, Texas.
Daily valuation snapshot
See the complete daily valuation snapshot
These values come from the daily market snapshot dated 2026-10-09. TTM means trailing twelve months. Use the market date when comparing TIL with another company.
Scroll sideways to compare all columns. Select a heading to sort.
| Daily close (USD) | $6.74 |
| Market capitalization (USD) | $45,710,518.24 |
| Price / earnings (TTM) | Not reported |
| Price / book | 0.43 |
No matching rows. Clear the filter to see all records.
Read TIL's valuation metrics
Company size
Instil Bio, Inc. Common Stock's recorded market capitalization is $45,710,518.24. It measures the market value of the company's equity, rather than its revenue or cash balance.
Price relative to earnings
P/E compares share price with trailing annual earnings per share. For a company with losses, inspect the earnings figures directly rather than treating a negative multiple as a cheap valuation.
Price relative to book equity
TIL's recorded price-to-book ratio is 0.43. That compares its market equity value with recorded book equity. Examine its business and balance sheet to understand why those values differ.
Research Instil Bio, Inc. Common Stock with Aurora
Use the snapshot above to ask a specific question about TIL. Ask for the report period and the figures behind the explanation, then compare the answer with the company's business description.
Continue the research
Follow TIL's ownership disclosures to see who filed a transaction or position and when it became public. To turn a research idea into a strategy, define an entry rule and test its dated observations.